São Paulo State announced on Monday that the free vaccination against COVID-19 with the Chinese vaccine developed by Sinovac Biotech will begin on January 25 up to March 28. Sinovac and Butantan Institute biomedical center are undergoing late-stage testing at 16 locations in Brazil.
Coronavac is pending regulatory approval by Anvisa and the efficacy results that may be presented by December 15.
In a press conference, São Paulo’s governor João Doria said that the immunization will have two doses per person, with an interval of 21 days between the two. Among the priority groups, the first to be immunized will be health professionals, indigenous and quilombolas people, in a total of 1.5 million people.
From February 8, the elderly aged 75 years or older will be immunized. The following week, starting on February 15th, it will be the turn of the elderly between 70 and 74 years old. On February 22, the immunization will be given to the age group of 65 to 69 years. On March 1st, individuals aged 60 to 64 years will be vaccinated.
According to São Paulo’s governor, 18 million doses will be applied in this vaccination program.
So far, Brazil’s federal government’s principal bet has been on a vaccine being developed by AstraZeneca, that may begin the immunization in March 2021.
The application of the Pfizer vaccine in the United Kingdom begins on Tuesday, the British government announced. The priority will be for seniors over 80, health professionals, and residents of nursing homes. The UK has a contract with Pfizer to receive 40 million doses, which will allow it to immunize 20 million people.